• Sanofi Launches Phase 2 Trial to Treat PD Patients with Gaucher-Causing Mutation
  • Researchers Identify Genetic ‘Switch’ for Mitochondrial Health in Parkinson’s Neurons
  • New Brain Imaging Tools Allow for Scanning at Cell Level and While Moving About
  • Biomarker in Blood Tests May Help Distinguish Parkinson’s from Similar Diseases
  • Axovant Publicizes Preliminary Results of Phase 2 Trial of Nelotanserin
  • Parkinson’s Foundation Adding Cities to Its National Moving Day Walks Fundraiser
  • Lowering Level of Protein Could Prevent Mutation From Triggering Parkinson’s, Study Suggests
  • Therapy for Off Periods in Parkinson’s Shows Efficacy in Phase 3 Clinical Trial
  • Study of Salt Levels on Alpha-synuclein Aggregates May Shed New Light on Parkinson’s
  • Parkinson’s Foundation Adds Two New Centers of Excellence to Global Network
  • Yoga May Help Ease Stiffness, Poor Balance Associated with Parkinson’s Disease: Here’s How
  • Side Effects Seen to Limit Long-Term Use of Apomorphine Infusions in Parkinson’s